Group 1 - The core viewpoint of the news is the performance and financial details of He Eye Hospital Group, which saw a stock price increase of 1.29% to 19.69 CNY per share, with a total market capitalization of 3.112 billion CNY [1] - He Eye Hospital Group, established on October 15, 2009, and listed on March 22, 2022, primarily provides specialized ophthalmic diagnosis and treatment services, with revenue breakdowns including 30.24% from vision services, 24.16% from refractive surgery, and 13.68% from cataract treatment [1] - The company reported a trading volume of 8.6667 million CNY and a turnover rate of 0.36% [1] Group 2 - Among the top ten circulating shareholders of He Eye Hospital, the Rongtong Health Industry Flexible Allocation Mixed A/B fund reduced its holdings by 93,200 shares, now holding 2.7015 million shares, which is 2.22% of the circulating shares [2] - The Rongtong Health Industry Flexible Allocation Mixed A/B fund, established on December 25, 2014, has a current scale of 1.816 billion CNY, with a year-to-date return of 8.73% and a one-year return of 6.27% [2] - The fund manager, Wan Minyuan, has a tenure of 9 years and 130 days, with the best fund return during this period being 131.32% [3]
何氏眼科股价涨1.29%，融通基金旗下1只基金位居十大流通股东，持有270.15万股浮盈赚取67.54万元